EUVIMEDEUVIMED entdecken
Open Access

Signaling Network Response to α-Particle–Targeted Therapy with the 225 Ac-Labeled Minigastrin Analog 225 Ac-PP-F11N Reveals the Radiosensitizing Potential of Histone Deacetylase Inhibitors

Yun Qin, Stefan Imobersteg, Stephan Frank, Alain Blanc, Tanja Chiorazzo, Philipp Berger, Roger Schibli, Martin P Béhé, Michal Grzmil

Journal of Nuclear Medicine · 2023-06 · 64 (6) · 873-879

DOI: 10.2967/jnumed.122.264597 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 02.02.2023. Verfasst von Yun Qin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Radiopharmaceutical Sciences, Paul Scherrer Institute, Villigen, Switzerland. Hauptthemen laut MEDLINE: Histone Deacetylase Inhibitors, Tumor Suppressor Protein p53. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Histone Deacetylase InhibitorsTumor Suppressor Protein p53AnimalsMiceMice, NudeCell Line, TumorVorinostatSignal TransductionHydroxamic AcidsGastrins

Stichwörter der Autor:innen

225AcCCKBRminigastrinphosphoproteomicsradioresistance

Substanzen

Histone Deacetylase InhibitorsTumor Suppressor Protein p53VorinostatHydroxamic AcidsminigastrinGastrins

Autor:innen und Institutionen

  • Center for Radiopharmaceutical Sciences, Paul Scherrer Institute, Villigen, Switzerland.
  • Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland.
  • Division of Neuropathology, Institute of Pathology, University of Basel, Basel, Switzerland; and.
  • Laboratory of Nanoscale Biology, Paul Scherrer Institute, Villigen, Switzerland.
  • Center for Radiopharmaceutical Sciences, Paul Scherrer Institute, Villigen, Switzerland; martin.behe@psi.ch michal.grzmil@psi.ch.

Zitieren

APA

Qin, Y., Imobersteg, S., Frank, S., Blanc, A., Chiorazzo, T., Berger, P., Schibli, R., Béhé, M. P., & Grzmil, M. (2023). Signaling Network Response to α-Particle–Targeted Therapy with the 225 Ac-Labeled Minigastrin Analog 225 Ac-PP-F11N Reveals the Radiosensitizing Potential of Histone Deacetylase Inhibitors. Journal of Nuclear Medicine, 64(6), 873-879. https://doi.org/10.2967/jnumed.122.264597

Vancouver

Qin Y, Imobersteg S, Frank S, Blanc A, Chiorazzo T, Berger P, et al. Signaling Network Response to α-Particle–Targeted Therapy with the 225 Ac-Labeled Minigastrin Analog 225 Ac-PP-F11N Reveals the Radiosensitizing Potential of Histone Deacetylase Inhibitors. Journal of Nuclear Medicine. 2023;64(6):873-879. doi:10.2967/jnumed.122.264597

BibTeX
@article{Qin2023,
  author = {Qin, Yun and Imobersteg, Stefan and Frank, Stephan and Blanc, Alain and Chiorazzo, Tanja and Berger, Philipp and Schibli, Roger and Béhé, Martin P and Grzmil, Michal},
  title = {Signaling Network Response to α-Particle–Targeted Therapy with the 225 Ac-Labeled Minigastrin Analog 225 Ac-PP-F11N Reveals the Radiosensitizing Potential of Histone Deacetylase Inhibitors},
  journal = {Journal of Nuclear Medicine},
  year = {2023},
  volume = {64},
  number = {6},
  pages = {873--879},
  doi = {10.2967/jnumed.122.264597}
}
Kostenlos starten →